Target intelligence / Profile preview

Long intergenic non-protein coding RNA 663 (LINC00663)

Target
LINC00663
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA
01

Overview

Long intergenic non-protein coding RNA 663 (LINC00663) is a human long non-coding RNA gene that does not encode a protein product. It is primarily localized in the nucleus and functions as a gene regulator, partly through interacting with transcription factors such as EBF1 to upregulate other genes like NR2F1. LINC00663 is overexpressed in various cancers, including bladder, pancreatic, and glioma, where it fosters cell proliferation, inflammation, and angiogenesis. Loss of LINC00663 suppresses tumor growth and inflammatory signaling in preclinical studies. While not a classical therapeutic target, it is of increasing interest for its roles in oncogenesis and as a potential cancer biomarker.

Other names
MGC39821lincRNA-663Long intergenic non-protein coding RNA 663
02

Mechanism of action

Not applicable for drugs, as there are no known drugs targeting this lncRNA. Mechanistically, LINC00663 acts by scaffolding transcription factors (e.g., EBF1) to gene promoters (e.g., NR2F1), thereby regulating the expression of downstream genes involved in cancer development and inflammation.

03

Biological functions

Gene regulation (primarily at the transcriptional level)Regulation of cell proliferation and invasion in cancerRegulation of inflammatory signaling and angiogenesisNuclear localization, suggesting a role in chromatin or transcriptional control
04

Disease associations

Cancer (studied in bladder cancer, pancreatic cancer, glioma)Inflammation (implicated in inflammatory mechanisms in the tumor microenvironment)Potential broader oncogenic activity in multiple cancers
05

Safety considerations

Not applicable (no direct therapies targeting LINC00663). Therapeutic targeting of lncRNAs is still largely experimental, with challenges including delivery, specificity, and unintended off-target gene regulation.
06

Biomarkers

High LINC00663 expression may be a biomarker for certain cancers (bladder, pancreatic, glioma)Its overexpression correlates with tumor proliferation, invasion, angiogenesis, and poor prognosis in select studies

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 663 (LINC00663).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 663 (LINC00663).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call